Back to NGNE
UBS Group AG NGNE Position History
Neurogene Inc. • Healthcare
Quarters held
13
Latest value
$11.6M
Q3 2026
Peak value
$11.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $75K |
| Q3 2025 | $3.9M |
| Q3 2025 | $1K |
| Q4 2025 | $89K |
| Q4 2025 | $3.1M |
| Q4 2025 | $639 |
| Q1 2026 | $1K |
| Q1 2026 | $3.7M |
| Q1 2026 | $63K |
| Q2 2026 | $2K |
| Q2 2026 | $5.4M |
| Q3 2026 | $2K |
| Q3 2026 | $11.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $11.6M | 417.6K | — | — |
| Q3 2026 | $2K | 88 | — | — |
| Q2 2026 | $5.4M | 171.2K | — | — |
| Q2 2026 | $2K | 62 | — | — |
| Q1 2026 | $63K | 3.1K | — | — |
| Q1 2026 | $3.7M | 182.5K | — | — |
| Q1 2026 | $1K | 70 | — | — |
| Q4 2025 | $639 | 31 | — | — |
| Q4 2025 | $3.1M | 149.8K | — | — |
| Q4 2025 | $89K | 4.3K | — | — |
| Q3 2025 | $1K | 79 | — | — |
| Q3 2025 | $3.9M | 223.3K | — | — |
| Q3 2025 | $75K | 4.3K | — | — |
Other funds holding NGNE
$51.9M
$51.7M
$48.6M
$44.4M
$44.1M
$43.5M
$42.8M